# Ramipril for the Treatment of Oligospermia

> **NCT01856361** · NA · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 2 (actual)

## Conditions studied

- Oligospermia
- Teratospermia
- Asthenozoospermia
- Male Infertility

## Interventions

- **DRUG:** Ramipril
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01856361
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** We did not accrue as much as anticipated and the PI (Dabaja) is no longer at Weill Cornell.
- **Last updated:** 2017-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01856361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01856361, "Ramipril for the Treatment of Oligospermia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01856361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*